![[NEWS] Max-Q: This week in space – Loganspace](https://i0.wp.com/loganspace.com/wp-content/uploads/2019/10/18952/news-max-q-this-week-in-space-8211-loganspace.jpg?resize=218%2C150&ssl=1 "[NEWS] Max-Q: This week in space – Loganspace")
![[Science] Weird repeating signals from deep space may be created by starquakes – AI](https://i0.wp.com/loganspace.com/wp-content/uploads/2019/10/18330/science-weird-repeating-signals-from-deep-space-may-be-created-by-starquakes-8211-ai.jpg?resize=218%2C150&ssl=1 "[Science] Weird repeating signals from deep space may be created by starquakes – AI")
![[NEWS] Relativity, a new star in the space race, raises $160 million for its 3-D printed rockets – Loganspace](https://i0.wp.com/loganspace.com/wp-content/uploads/2019/10/18141/news-relativity-a-new-star-in-the-space-race-raises-160-million-for-its-3-d-printed-rockets-8211-loganspace.jpg?resize=218%2C150&ssl=1 "[NEWS] Relativity, a new star in the space race, raises $160 million for its 3-D printed rockets – Loganspace")
![[NEWS] Relativity Space signs its the satellite transportation company Momentus as its first customer – Loganspace](https://i0.wp.com/loganspace.com/wp-content/uploads/2019/09/17152/news-relativity-space-signs-its-the-satellite-transportation-company-momentus-as-its-first-customer-8211-loganspace.jpg?resize=218%2C150&ssl=1 "[NEWS] Relativity Space signs its the satellite transportation company Momentus as its first customer – Loganspace")
![[NEWS] In latest $10B JEDI contract twist, Defense Secretary recuses himself – Loganspace](https://i0.wp.com/loganspace.com/wp-content/uploads/2019/10/19024/news-in-latest-10b-jedi-contract-twist-defense-secretary-recuses-himself-8211-loganspace.jpg?resize=218%2C150&ssl=1 "[NEWS] In latest $10B JEDI contract twist, Defense Secretary recuses himself – Loganspace")
![[NEWS] Exclusive: As North Korea expands arsenal, Japan’s missile defense shield faces unforeseen costs – sources – Loganspace AI](https://i0.wp.com/loganspace.com/wp-content/uploads/2019/09/17971/news-exclusive-as-north-korea-expands-arsenal-japan8217s-missile-defense-shield-faces-unforeseen-costs-8211-sources-8211-loganspace-ai.jpg?resize=218%2C150&ssl=1 "[NEWS] Exclusive: As North Korea expands arsenal, Japan’s missile defense shield faces unforeseen costs – sources – Loganspace AI")
![[NEWS] China destabilizing Indo-Pacific: U.S. Defense Secretary – Loganspace AI](https://i0.wp.com/loganspace.com/wp-content/uploads/2019/08/15296/news-china-destabilizing-indo-pacific-us-defense-secretary-8211-loganspace-ai.jpg?resize=218%2C150&ssl=1 "[NEWS] China destabilizing Indo-Pacific: U.S. Defense Secretary – Loganspace AI")
![[NEWS] U.S. Defense Secretary says he favors placing missiles in Asia – Loganspace AI](https://i0.wp.com/loganspace.com/wp-content/uploads/2019/08/15258/news-us-defense-secretary-says-he-favors-placing-missiles-in-asia-8211-loganspace-ai.jpg?resize=218%2C150&ssl=1 "[NEWS] U.S. Defense Secretary says he favors placing missiles in Asia – Loganspace AI")
![[Science] Promising treatment for chronic fatigue syndrome fails large trial – AI](https://i0.wp.com/loganspace.com/wp-content/uploads/2019/04/7190/science-promising-treatment-for-chronic-fatigue-syndrome-fails-large-trial-8211-ai.jpg?fit=1200%2C800&ssl=1 "science-promising-treatment-for-chronic-fatigue-syndrome-fails-large-trial-8211-ai.jpg")
iStock / Getty Images PlusBy Clare Wilson A medicine that people hoped would treat chronic fatigue syndrome (CFS) has failed its first large placebo-controlled trial. The drug, called rituximab, is used to treat cancer and autoimmune diseases in which the immune system makes antibodies that turn against the body. The medicine works by killing the cells that make antibodies. Advertisement A few people who had cancer and also happened to have CFS saw their symptoms of fatigue resolve after taking rituximab. Øystein Fluge of Haukeland University Hospital in Norway thought …